Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Renal Cell × Data Collection × Clear all

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Papillomavirus Infections 7 Uterine Cervical Neoplasms 4 Neuroendocrine Tumors 4 Neoplasms 4 Autoimmune Diseases 3 Ovarian Neoplasms 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Venous Thrombosis 1 Venous Thromboembolism 1 Thyroid Diseases 1 Thrombosis 1 Retinal Telangiectasis 1 Renal Insufficiency 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Leukemia, Hairy Cell 1 Hemorrhage 1 Hematologic Neoplasms 1 Fanconi Anemia, Complementation Group D1 1 Desmoid Tumors 1 Cysts 1 Colonic Neoplasms 1

Interventions

Sunitinib 69 Sorafenib 49 pazopanib 40 Nivolumab 40 Everolimus 40 Bevacizumab 36 pembrolizumab 30 Interferon-alpha 26 aldesleukin 25 temsirolimus 21 cabozantinib 19 Axitinib 19 Ipilimumab 16 Interleukin-2 14 Cyclophosphamide 13 fludarabine phosphate 12 Interferon alpha-2 12 Gemcitabine 12 Peripheral Blood Stem Cell Transplantation 10 Paclitaxel 10 Erlotinib Hydrochloride 9 Docetaxel 8 Capecitabine 8 tremelimumab 7 Sirolimus 7 Fluorouracil 7 sargramostim 6 lenvatinib 6 Introns 6 Fluorodeoxyglucose F18 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03419572 2022-08-15

CASSIOPE

Ipsen

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡